LXRX Message Board Post 10945936 | Lexicon Pharmaceuticals...
home / stock / lxrx / lxrx message board
(investorshangout)
Posted on: Apr/21/2023 16:35:49
Source: investorshangout
https://investorshangout.com/post/view?id=6564815
whytestocks: $LXRX News Article - Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia
News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
Market:
Lexicon Pharmaceuticals Inc. Website:
-
Commercial launch of INPEFA ® (sotagliflozin) for Heart Failure continues to progress Resubmission of NDA for ZYNQUISTA ™ (sotagliflozin) in Type 1 Diabetes expected mid-year 2024 Start-up ongoing for Phase 3 study of sotagliflozin...
-
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
-
THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that Lonnel Coats has prov...